Vascular Disrupting Agents (VDAs) are a unique class of drugs designed to specifically target the blood vessels that supply tumors. By attacking these vessels, VDAs can cut off the blood supply to cancer cells, potentially leading to tumor cell death. This approach shows promise as a supplementary strategy in cancer therapy, especially when combined with traditional treatments like chemotherapy. VDAs are a fascinating and evolving area of cancer research and drug development.
